PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-6.66%
Negative revenue growth while NXPI stands at 3.52%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-7.81%
Negative gross profit growth while NXPI is at 3.33%. Joel Greenblatt would examine cost competitiveness or demand decline.
-18.38%
Negative EBIT growth while NXPI is at 17.86%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-18.60%
Negative operating income growth while NXPI is at 17.86%. Joel Greenblatt would press for urgent turnaround measures.
-18.76%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-17.86%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-17.86%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
-0.91%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-0.81%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
6.82%
Dividend growth of 6.82% while NXPI is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
4.17%
OCF growth at 75-90% of NXPI's 5.37%. Bill Ackman would demand better working capital management or cost discipline.
6.33%
FCF growth above 1.5x NXPI's 0.43%. David Dodd would verify if the firm’s strategic investments yield superior returns.
160.86%
Positive 10Y revenue/share CAGR while NXPI is negative. John Neff might see a distinct advantage in product or market expansion over the competitor.
43.38%
Positive 5Y CAGR while NXPI is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
-7.30%
Negative 3Y CAGR while NXPI stands at 58.84%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
168.15%
10Y OCF/share CAGR under 50% of NXPI's 1090.50%. Michael Burry would worry about a persistent underperformance in cash creation.
26.50%
Below 50% of NXPI's 1090.50%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
5.20%
3Y OCF/share CAGR under 50% of NXPI's 118.94%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
137.70%
Net income/share CAGR 1.25-1.5x NXPI's 122.26%. Bruce Berkowitz might see more effective use of capital or consistently better margins over time.
463.32%
5Y net income/share CAGR above 1.5x NXPI's 122.26%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
-41.46%
Negative 3Y CAGR while NXPI is 182.25%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
117.37%
10Y equity/share CAGR above 1.5x NXPI's 21.99%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
36.69%
5Y equity/share CAGR above 1.5x NXPI's 21.99%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
11.74%
Below 50% of NXPI's 33.40%. Michael Burry suspects a serious short-term disadvantage in building book value.
2060.94%
Dividend/share CAGR of 2060.94% while NXPI is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
172.72%
Dividend/share CAGR of 172.72% while NXPI is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
129.94%
3Y dividend/share CAGR of 129.94% while NXPI is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
-21.06%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
0.29%
We show growth while NXPI is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
-1.59%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
-1.31%
We have a declining book value while NXPI shows 8.36%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-0.06%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
-5.98%
Our R&D shrinks while NXPI invests at 3.07%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-0.86%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.